HPV Prevalence in Transpersons - a Prospective Study

Transsexualism Clinical Trial

Official title: HPV Prevalence in Transpersons - a Prospective Study

Status Completed

Clinical Trial Summary

In this study, Human Papilloma Virus (HPV) prevalence will be determined once in the urine of 200 trans people. In addition, subjects will be asked to complete a questionnaire about their sexual orientation, which is adapted from the largest published study.

Clinical Trial Description

All transpeople who visit the outpatient clinic are asked to participate in the study. After being informed and signing the Informed Consent Form, the subjects are asked to give first-void urine and fill out the survey. The urine samples are sent pseudonymously to the University of Ljubljana for analysis. The subjects will be informed about their results within 3 weeks.If the result is positive, the subjects will be offered voluntary further care in our HPV outpatient clinic. However, this will take place outside the study. The data collected there can be used for further analyses. ;

Related Conditions & MeSH terms

• Papillomavirus Infection
• Papillomavirus Infections
• Transsexualism

• NCT number: NCT04864951
• Study type: Interventional
• Source: Medical University of Vienna
• Status: Completed
• Phase: N/A
• Start date: May 2, 2021
• Completion date: November 1, 2021